Tag: Epilepsy Surgery

Reflections on the life and career of Dr. Juhn Wada (1924-2023)

sarah JonasFeature

Juhn Atsushi Wada was a Japanese–Canadian neurologist known for research on epilepsy and brain asymmetry, including the development of the Wada test to assess hemispheric dominance of language function. He became a pioneer in the utilization of the kindling model of epilepsy, which permitted controlled studies of the development of epilepsy in the laboratory.

What is a Wada Test? CHLA’s Dr. Sucheta Joshi Tells Parents What to Expect

sarah Jonasblog

For children who are undergoing evaluation for surgery to treat epilepsy at Children’s Hospital Los Angeles, the Wada test, also known as the intracarotid amobarbital procedure, can be an important step in the process. During this test, doctors put certain areas of the brain to sleep to help pinpoint which areas correspond to the patient’s language and memory.

Superar las barreras quirúrgicas en áreas de bajos recursos

sarah JonasFeature

Hasta la mitad de las personas con epilepsia resistente a los medicamentos (ERD) pueden beneficiarse de la cirugía. Sin embargo, en muchas regiones de bajos recursos, el establecimiento de un programa quirúrgico requiere enfrentar múltiples desafíos.

Après une chirurgie de l’épilepsie : gérer les attentes et les soins

sarah JonasFeature

Avant la chirurgie, les personnes atteintes d’épilepsie subissent une longue évaluation et des tests approfondis. Mais après une opération chirurgicale, certains professionnels et défenseurs affirment que les gens sont injustement laissés seuls pour gérer le traitement et les soins, sans beaucoup d’aide ou de conseils.

Children With Drug-Resistant Epilepsy Live Longer After Cranial Surgery

sarah JonasResearch Results

Survival rate beyond 10 years in children with drug-resistant epilepsy (DRE) was highest after cranial epilepsy surgery and lowest when treated only with antiseizure medications, according to a study published in The Lancet Child and Adolescent Health. This large, retrospective study was the first to compare long-term survival in children with DRE among cohorts treated with medications only, vagus nerve stimulation plus medications, and cranial epilepsy surgery plus medications. Results show that risk of early death was reduced by over 80 percent after surgery and by 40 percent after vagus nerve stimulation, compared to medication-only treatment.

Lurie Children’s Approved for $4 Million in Funding for Study on Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications For Lennox-Gastaut Syndrome

sarah JonasAnnouncement

Anne Berg, PhD, Research Professor, and Sandi Lam, MD, MBA, Chief of Neurosurgery at Ann & Robert H. Lurie Children’s Hospital of Chicago have been approved for a $4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to conduct a study, Comparative effectiveness of palliative surgery versus additional anti-seizure medications for Lennox-Gastaut Syndrome.